These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2982296)

  • 1. Equine herpesvirus type 2: cell-virus relationship during persistent cell-associated viremia.
    Gleeson LJ; Coggins L
    Am J Vet Res; 1985 Jan; 46(1):19-23. PubMed ID: 2982296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of pregnant mares to equine herpesvirus 1 (EHV1).
    Gleeson LJ; Coggins L
    Cornell Vet; 1980 Oct; 70(4):391-400. PubMed ID: 6257449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of transabdominal ultrasound-guided amniocentesis for detection of equid herpesvirus 1-induced fetal infection in utero.
    Smith KC; McGladdery AJ; Binns MM; Mumford JA
    Am J Vet Res; 1997 Sep; 58(9):997-1002. PubMed ID: 9285004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
    Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N; Bridges CG
    Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
    Stokes A; Corteyn AH; Murray PK
    Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
    Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interference between equine herpesvirus types 1 and 2.
    Dutta SK; Myrup AC; Thaker SR
    Am J Vet Res; 1986 Apr; 47(4):747-50. PubMed ID: 2421620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic relationships of equine herpesvirus strains demonstrated by the plaque reduction and neutralization kinetics tests.
    Kemeny LJ
    Can J Comp Med; 1971 Oct; 35(4):279-84. PubMed ID: 4338672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzyme-linked immunosorbent assay (ELISA) for measurement of antibodies against equine herpesvirus 2 in equine sera.
    Fu ZF; Denby L; Lien DH; Robinson AJ
    Acta Virol; 1987 Nov; 31(6):468-74. PubMed ID: 2894140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of equine herpesvirus-1 antigen and the specific antibody by enzyme-linked immunosorbent assay.
    Dutta SK; Talbot NC; Myrup AC
    Am J Vet Res; 1983 Oct; 44(10):1930-4. PubMed ID: 6314855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine rhinopneumonitis virus (herpesvirus type 1): attenuation in stable monkey cell line.
    Purdy CW; Ford SJ; Grant WF
    Am J Vet Res; 1977 Aug; 38(8):1211-5. PubMed ID: 199093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.